Condition
glp1 Agonist
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Not Yet Recruiting3
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07787533Not ApplicableNot Yet Recruiting
Digital Resistance Training for Midlife Women Using GLP-1
NCT07731256Phase 2Not Yet Recruiting
Semaglutide for Low Back Pain
NCT07224880RecruitingPrimary
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
NCT07175805Not Yet Recruiting
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy
Showing all 4 trials